NCT01901887 (BRAVO) is a Phase 1 clinical trial of Study Juice in Suicide, sponsored by Medical University of South Carolina.

Who is sponsoring NCT01901887?

NCT01901887 is sponsored by Medical University of South Carolina.

What drugs are being tested in NCT01901887?

Interventions in NCT01901887: Study Juice, Placebo Juice.

Is NCT01901887 still recruiting?

NCT01901887 is currently terminated. Last updated 12 June 2018.

Last reviewed 2018-06-12 · How we verify

NCT01901887: BRAVO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Better Resiliency Among Veterans With Omega-3's (BRAVO) Study

Terminated Phase 1 Last updated 12 June 2018

What this trial tests

Phase 1 trial testing Study Juice in Suicide in 125 participants. Terminated before completion.

Timeline

1 March 2014

Primary endpoint
30 August 2016

30 August 2016

Quick facts

Lead sponsor	Medical University of South Carolina
Phase	Phase 1
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	125
Start date	1 March 2014
Primary completion	30 August 2016
Estimated completion	30 August 2016
Sites	1 location across United States

Drugs / interventions tested

Study Juice — full drug profile →
Placebo Juice — full drug profile →

Conditions studied

Suicide — all drugs for Suicide →

Sponsor

Medical University of South Carolina

Who can join

Adults 18 to 90, any sex, with Suicide. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The BRAVO study seeks to determine if dietary supplementation with omega-3 highly unsaturated fatty acids (omega-3 HUFAs) reduces the risk for serious suicidal behaviors, suicidal thinking, negative emotions, and symptoms associated with suicide risk, in a Veteran and non-Veteran population that is at risk for suicidal behaviors. This study seeks to evaluate the efficacy of omega-3 HUFAs among a representative population of US Veterans and non-Veterans already receiving appropriate medical care so that if successful, these results can be readily applied to broader populations in the US.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Omega-3 fatty acids for depression in adults.
Appleton KM, Voyias PD, Sallis HM, Dawson S, et al · · 2021 · cited 48× · PMID 34817851 · DOI 10.1002/14651858.cd004692.pub5
Evaluating cognitive effort in a randomized controlled trial.
Turner TH, Renfroe JB, Morella K, Marriott BP, et al · · 2016 · cited 3× · PMID 27074873 · DOI 10.1002/mpr.1505

Verify or expand the search:

Other recruiting trials for Suicide

Currently open trials in the same condition.

NCT07404787 — Evaluation of a Telehealth Case Management Intervention to Prevent Suicide Among Soldiers Discharged From Psychiatric Ho · NA · recruiting
NCT07214233 — Youth Empowerment and Safety Intervention · NA · recruiting
NCT07343258 — Pilot Study on Follow-Up of (Acutely) Suicidal Individuals From the Flemish Suicide Helpline · NA · recruiting
NCT07523490 — Investigation on Suicide Risk Factors of Patients With Mood Disorders · recruiting
NCT06571916 — Brief Skills for Safer Living (Brief-SfSL) · NA · recruiting

Other Medical University of South Carolina trials

Trials by the same sponsor.

NCT06491264 — Multiparameter Optimized tES for Memory in Aging · NA · withdrawn
NCT07513389 — Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION) · Phase 2 · not yet recruiting
NCT03101917 — Microtable® Method for Cochlear Implantation Investigational Device Exemption (IDE) · NA · not yet recruiting
NCT07149207 — Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors · Phase 2 · recruiting
NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01901887 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of South Carolina
Last refreshed: 12 June 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01901887.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing